An intravenously administered, single-dose monoclonal antibody intended to reduce recurrence of Clostridium difficile infection (CDI) in adult patients receiving antibacterial drug treatment for CDI who are at high risk for recurrence.
If you have a Hayes login, click here to view the full report on the Knowledge Center.